Why are colloids not recommended for treating hypovolemic shock in adults?

Why Colloids Are Not Recommended for Hypovolemic Shock

Colloids are not routinely recommended for hypovolemic shock because they fail to demonstrate survival benefit over crystalloids, impair coagulation and platelet function (particularly hydroxyethyl starch and gelatin solutions), carry risks of renal dysfunction, and are significantly more expensive without proven clinical advantage. 1

Primary Rationale: Lack of Mortality Benefit

• Meta-analyses consistently show no survival advantage when comparing colloids (including starch solutions, gelatin, and albumin) to crystalloids in surgical patients requiring hypovolemic resuscitation 1
• The 2023 European trauma guidelines explicitly state that colloids "failed to demonstrate a benefit on survival" compared to crystalloids 1
• A systematic review of 37 randomized trials found colloid resuscitation was associated with an increased absolute risk of mortality of 4% (four extra deaths per 100 patients resuscitated) 2
• Recent large-scale studies in critically ill surgical patients (n=741) found no difference in 28-day mortality (23.6% vs 26%) or 90-day mortality between crystalloids and colloids 3

Critical Safety Concerns with Colloids

Coagulopathy Risk

• All hydroxyethyl starch and gelatin solutions impair coagulation and platelet function 1
• This is identified as "the main rationale for the primary use of crystalloids" in traumatic hemorrhagic shock 1
• Hydroxyethyl starch solutions cause dose-related coagulopathy, with activated partial thromboplastin time doubling and clot strength reduced by 15% 4
• These coagulation defects may be only partially improved with fibrinogen concentrate 1

Renal Dysfunction

• Hydroxyethyl starch solutions are associated with acute kidney injury and impaired renal function, particularly when manufacturer dose limits are exceeded 5, 6
• The FLASH study showed renal failure was significantly more frequent with hydroxyethyl starch (OR 1.34, p=0.05) 7
• Older HES preparations (hetastarch, hexastarch, pentastarch) have repeatedly been reported to impair renal function 6

Other Adverse Effects

• Anaphylactic reactions: Colloids carry risk of anaphylaxis, with dextrans having the highest anaphylactoid potential 8, 6
• Infection hazard: Colloids are biological products with potential infection risk 8
• Tissue storage: Synthetic colloids cause dose-related tissue accumulation 5

Economic Considerations

• Colloids are dramatically more expensive than crystalloids without proven benefit 8
• Cost comparison per liter: Albumin €140 ($152), HES €25 ($27), versus isotonic saline €1.5 ($1.6) 8
• This represents approximately 50-100 times higher cost for colloids 9

Current Guideline Recommendations

Initial Resuscitation Strategy

• The 2023 European trauma guidelines (Grade 1C) recommend restricting colloid use due to adverse effects on hemostasis 1
• Crystalloid solutions are recommended as first-line therapy for initial resuscitation in hypotensive bleeding trauma patients (Grade 1B) 1
• A restrictive volume strategy using crystalloid solutions is "generally accepted" for the initial phase of traumatic hemorrhagic shock 1

Pediatric Guidelines

• The Dutch Pediatric Society guidelines recommend isotonic saline as first-choice fluid for initial resuscitation in neonates and children with hypovolemia (Grade A) 8
• The guideline committee concluded that colloid benefits over crystalloids "should be proved before they were used" 8

Limited Role for Colloids

• Colloids may be considered only as a rescue option when bleeding is excessive and crystalloids combined with vasopressors fail to maintain basic tissue perfusion 1
• When large fluid volumes are required (e.g., sepsis), synthetic colloids may be considered due to longer intravascular duration, but this is a weak recommendation (Grade C) 8

Crystalloid Efficacy

• Crystalloids require less volume than traditionally suggested: Clinical evidence shows comparable resuscitation with <2-fold the volume of colloids, not the 3-4 fold ratio often cited 5
• The actual volume ratio from the SAFE study was only 1.4:1 (albumin to saline), not the theoretical 3:1 8
• While colloids can reduce fluid requirements (ratio of 1.5:1), this does not translate to improved clinical outcomes 1

Special Considerations

Traumatic Brain Injury

• Hypotonic solutions including Ringer's lactate and hypotonic albumin should be avoided in patients with severe head trauma to minimize fluid shift into damaged cerebral tissue (Grade 1B) 1

Balanced vs. Unbalanced Crystalloids

• Balanced electrolyte solutions are favored over 0.9% sodium chloride as the initial crystalloid in trauma patients 1
• If 0.9% saline is used, it should be limited to maximum 1-1.5 L 1

Common Pitfalls to Avoid

• Do not assume newer colloids are safer: Third-generation HES 130/0.4 lacks adequate long-term safety data in critically ill patients, with most trials having observation periods of only 24-48 hours 5
• Do not exceed manufacturer dose limits: Adverse effects of colloids are dose-dependent and worsen when recommended doses are exceeded 5, 6
• Do not use colloids for routine resuscitation: Reserve for situations where crystalloids plus vasopressors have failed 1